Properties
Related Categories: Apolipoproteins, Biochemicals and Reagents, Cell Biology, Cell Signaling and Neuroscience, Cholesterol and Cholesterol Metabolism,
Quality level: 100
Assay: ≥95% (HPLC)
Form: lyophilized
Color: White
Solubility: H2O:> 1 mg / mL
Storage temperature. −20 ° C
Description
Packaging: 1 mg in a glass bottle
Biochemical / Physiological Actions
COG 1333 or apoE (133-149) is an apolipoprotein E (APOE) fragment that mimics the functional anti-inflammatory and neuroprotective effects of intact apoE protein. It was suggested that the neuroprotective functions of the mimetic result from binding to low-density lipoprotein receptor (LRP) -related protein or LDL receptors, and such binding results in inhibition of the N-methyl-D-aspartate receptor. (NMDA).
Rabbit Anti Human JAK2 Monoclonal Clone COG-10 |
||
| IRBAHUJAK2COG10C100UL | each | EUR 496 |
|
Description: Rabbit Anti Human JAK2 Monoclonal Clone COG-10 |
||
Apolipoprotein E fragment (133-149) – COG133 |
||
| SB180 | 1 | EUR 128.56 |
|
Description: Apolipoprotein E fragment (133-149) – COG133: acetyl-LRVRLASHLRKLRKRLL-NH2 (CAS : 514200-66-9) SB-PEPTIDE offers Apolipoprotein E (ApoE) mimetic peptide COG133 – LRVRLASHLRKLRKRLL – which competes with the ApoE holoprotein for binding the low density lipoprotein (LDL) receptor. Apolipoprotein E (ApoE): A key player in lipid transport and beyond Apolipoprotein E (apoE) is a low-density lipoprotein (LDL) receptor ligand that belongs to the family of fat-binding proteins, known as apolipoproteins. While the liver and macrophages primarily produce ApoE in peripheral tissues to mediate cholesterol metabolism, in the central nervous system (CNS), astrocytes take the lead in producing ApoE. ApoE plays a vital role in lipid transport, facilitating the movement of lipids such as fats, cholesterol, and fat-soluble vitamins between organs via plasma and interstitial fluids. In the central CNS, it serves as a crucial cholesterol carrier, promoting neuron survival, sprouting, and exhibiting functional anti-inflammatory and neuroprotective effects.Beyond its role in lipid transport, ApoE binds to a diverse range of cellular receptors, influencing immune responses, promoting cell migration, and potentially impacting transcription regulation.With its multifaceted functions, ApoE stands as a cornerstone in maintaining plasma and tissue lipid homeostasis and orchestrating complex interplays within the body. ApoE(133-149) mimetic peptide : COG 133 COG 133 mimetic peptide, takes the incredible capabilities of acting the same way as the LDL receptor-binding domain of ApoE. Therefore, this peptide wields a non-competitive stance against the alpha-7 nicotinic acetylcholine receptor, which is not only implicated in long-term memory but also in neurotoxicity, stroke, myocardial infarction, sepsis, Alzheimer’s disease, cancer progression, and angiogenic/neurogenic activity. Moreover, COG133’s anti-apoptotic effects further accentuate its potential.By mimicking ApoE, COG 133 / ApoE(133-149) masterfully inhibits the NMDA receptor channel function through interactions with the low-density lipoprotein receptor-related protein. The peptide emerged as a potent agent in reducing inflammation, cellular infiltration, and demyelination, making strides in animal models of multiple sclerosis (MS) and the 5-fluorouracil model of intestinal mucositis.Indeed, COG-133 emerged as a champion to suppress symptoms of experimental autoimmune encephalomyelitis (EAE), curbing inflammation, demyelination, and cell infiltration in the spinal cord. ApoE (133-149) fragment additionally showcased its prowess by decreasing TNF-α and nitric oxide (NO) release in BV-2 microglia and counteracting LPS-induced increases in brain levels of TNF-α and IL-6 in mice. The peptide also stands as a guardian of hippocampal neuronal health and offers promise in delaying disease onset and reducing severity of EAE mouse model. COG-133 applications The applications of COG 133 (ApoE 133-149) resonate across diverse fields of research and healthcare.Generally speaking, COG133’s multifaceted influences on inflammation, cellular responses, and neuronal health open doors to novel therapies for neurological disorders.Its potential as a groundbreaking tool in understanding and combating MS holds the promise of improved treatments and enhanced quality of life for patients suffering from this particular disease.SB-PEPTIDE is proud to offer this remarkable peptide for neurological research! |
||
Recombinant Neurospora crassa Conserved oligomeric Golgi complex subunit 6 (cog-6), partial |
||
| MBS1329607-INQUIRE | INQUIRE | Ask for price |
FTC-133 |
||
| ABC-TC0261 | 1 vial | Ask for price |
|
Description: Human follicular thyroid carcinoma, lymph node metastasis. FTC-133 was obtained from a lymph node metastasis of a follicular thyroid carcinoma not the primary tumour as originally reported from a 42-year-old male. |
||
JWH 133 |
||
| B7941-10 | 10 mg | EUR 428 |
JWH 133 |
||
| B7941-25 | 25 mg | EUR 924 |
JWH 133 |
||
| B7941-5 | 5 mg | EUR 268 |
RSC-133 |
||
| C4664-10 | 10 mg | EUR 193.6 |
|
Description: Stem Cell|iPSC |
||
RSC-133 |
||
| C4664-25 | 25 mg | EUR 428.8 |
|
Description: Stem Cell|iPSC |
||
RSC-133 |
||
| C4664-5 | 5 mg | EUR 108.8 |
|
Description: Stem Cell|iPSC |
||
JWH 133 |
||
| MBS132037-100mg | 100mg | EUR 1065 |
JWH 133 |
||
| MBS132037-500mg | 500mg | EUR 2775 |
JW 133 |
||
| J211220 | 25mg | EUR 9200 |
|
Description: 259869-55-1 |
||
MHP 133 |
||
| HY-101653 | 5mg | EUR 2637.6 |
|
Description: MHP 133 is a agent with multiple CNS targets, and inhibits acetylcholinesterase (AChE) with Ki of 69 μM; also active against muscarinic M1 and M2 receptors, serotonin 5HT4 receptors, and imidazole I2 receptors. |
||
JE-133 |
||
| HY-163151 | Get quote | Ask for price |
|
Description: JE-133 is an optically active isochromane-2H-chromene conjugate. JE-133 exhibits antioxidant and anti-inflammatory activities. JE-133 is a neuroprotective agent that effectively inhibits neuronal oxidative damage associated with PI3K/Akt and MAPK signaling pathways. JE-133 can also inhibit lipopolysaccharide (LPS) (HY-D1056)-induced neuroinflammation by regulating JAK/STAT and Nrf2 signaling pathways[1][2]. |
||
XY028-133 |
||
| HY-129180 | 10 mg | EUR 2056.31 |
|
Description: XY028-133 (example 14) is a PROTAC-based CDK4/6 degrader with anti-tumor activity, which consists of ligands for von Hippel-Lindau and CDK[1]. |
||
RM-133 |
||
| MBS5783842-INQUIRE | INQUIRE | Ask for price |
RSC-133 |
||
| MBS5757737-5mg | 5mg | EUR 915 |
RSC-133 |
||
| MBS5757737-5x5mg | 5x5mg | EUR 3970 |
MHP 133 |
||
| MBS5768102-5mg | 5mg | EUR 915 |
MHP 133 |
||
| MBS5768102-5x5mg | 5x5mg | EUR 3970 |
MHP 133 |
||
| MBS3844509-10mg | 10mg | EUR 3505 |
MHP 133 |
||
| MBS3844509-1mg | 1mg | EUR 1095 |
MHP 133 |
||
| MBS3844509-5mg | 5mg | EUR 2140 |
MHP 133 |
||
| MBS3844509-5x10mg | 5x10mg | EUR 15760 |
XY028-133 |
||
| T13361-10mg | 10mg | Ask for price |
|
Description: XY028-133 |
||
XY028-133 |
||
| T13361-1g | 1g | Ask for price |
|
Description: XY028-133 |
||
XY028-133 |
||
| T13361-1mg | 1mg | Ask for price |
|
Description: XY028-133 |
||
XY028-133 |
||
| T13361-50mg | 50mg | Ask for price |
|
Description: XY028-133 |
||
XY028-133 |
||
| T13361-5mg | 5mg | Ask for price |
|
Description: XY028-133 |
||
MHP 133 |
||
| T13772-10mg | 10mg | Ask for price |
|
Description: MHP 133 |
||
MHP 133 |
||
| T13772-1g | 1g | Ask for price |
|
Description: MHP 133 |
||
MHP 133 |
||
| T13772-1mg | 1mg | Ask for price |
|
Description: MHP 133 |
||
MHP 133 |
||
| T13772-50mg | 50mg | Ask for price |
|
Description: MHP 133 |
||
MHP 133 |
||
| T13772-5mg | 5mg | Ask for price |
|
Description: MHP 133 |
||
RM-133 |
||
| T34335-10mg | 10mg | Ask for price |
|
Description: RM-133 |
||
RM-133 |
||
| T34335-1g | 1g | Ask for price |
|
Description: RM-133 |
||
RM-133 |
||
| T34335-1mg | 1mg | Ask for price |
|
Description: RM-133 |
||
RM-133 |
||
| T34335-50mg | 50mg | Ask for price |
|
Description: RM-133 |
||
RM-133 |
||
| T34335-5mg | 5mg | Ask for price |
|
Description: RM-133 |
||
RSC-133 |
||
| T23271-10mg | 10mg | Ask for price |
|
Description: RSC-133 |
||
RSC-133 |
||
| T23271-1g | 1g | Ask for price |
|
Description: RSC-133 |
||
RSC-133 |
||
| T23271-1mg | 1mg | Ask for price |
|
Description: RSC-133 |
||
RSC-133 |
||
| T23271-50mg | 50mg | Ask for price |
|
Description: RSC-133 |
||
RSC-133 |
||
| T23271-5mg | 5mg | Ask for price |
|
Description: RSC-133 |
||
COG8 (Conserved Oligomeric Golgi Complex Subunit 8, COG Complex Subunit 8, Component of Oligomeric Golgi Complex 8) |
||
| MBS6008323-01mg | 0.1(mg | EUR 655 |
COG8 (Conserved Oligomeric Golgi Complex Subunit 8, COG Complex Subunit 8, Component of Oligomeric Golgi Complex 8) |
||
| MBS6008323-5x01mg | 5x0.1mg | EUR 2800 |
COG4, CT (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4) |
||
| MBS623968-02mL | 0.2mL | EUR 695 |
COG4, CT (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4) |
||
| MBS623968-5x02mL | 5x0.2mL | EUR 2975 |
COG4, CT (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4) (AP) |
||
| MBS6469589-02mL | 0.2mL | EUR 980 |
COG4, CT (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4) (AP) |
||
| MBS6469589-5x02mL | 5x0.2mL | EUR 4250 |
COG4, CT (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4) (APC) |
||
| MBS6469590-02mL | 0.2mL | EUR 980 |
COG4, CT (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4) (APC) |
||
| MBS6469590-5x02mL | 5x0.2mL | EUR 4250 |
COG4, CT (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4) (FITC) |
||
| MBS6469592-02mL | 0.2mL | EUR 980 |
COG4, CT (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4) (FITC) |
||
| MBS6469592-5x02mL | 5x0.2mL | EUR 4250 |
COG4, CT (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4) (HRP) |
||
| MBS6469593-02mL | 0.2mL | EUR 980 |
COG4, CT (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4) (HRP) |
||
| MBS6469593-5x02mL | 5x0.2mL | EUR 4250 |
COG4, CT (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4) (PE) |
||
| MBS6469599-02mL | 0.2mL | EUR 980 |
COG4, CT (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4) (PE) |
||
| MBS6469599-5x02mL | 5x0.2mL | EUR 4250 |
COG4, CT (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4) (Biotin) |
||
| MBS6469591-02mL | 0.2mL | EUR 980 |
COG4, CT (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4) (Biotin) |
||
| MBS6469591-5x02mL | 5x0.2mL | EUR 4250 |
COG8 (Conserved Oligomeric Golgi Complex Subunit 8, COG Complex Subunit 8, Component of Oligomeric Golgi Complex 8, FLJ22315, DOR1) |
||
| MBS6006845-005mg | 0.05(mg | EUR 630 |
COG8 (Conserved Oligomeric Golgi Complex Subunit 8, COG Complex Subunit 8, Component of Oligomeric Golgi Complex 8, FLJ22315, DOR1) |
||
| MBS6006845-5x005mg | 5x0.05mg | EUR 2680 |
Musclin (116-133) / Osteocrin (Ostn) (116-133) (Human) |
||
| 028-63 | 100 μg | EUR 255.96 |
Musclin (108-133) / Osteocrin (Ostn) (108-133) (Human) |
||
| 028-64 | 100 μg | EUR 140.4 |
Musclin (83-133) / Osteocrin (Ostn) (83-133) (Human) |
||
| 028-68 | 100 μg | EUR 497.88 |
COG6 (Conserved Oligomeric Golgi Complex Subunit 6, COG Complex Subunit 6, Component of Oligomeric Golgi Complex 6, KIAA1134, DKFZp313D191) |
||
| MBS6001835-01mg | 0.1(mg | EUR 630 |
COG6 (Conserved Oligomeric Golgi Complex Subunit 6, COG Complex Subunit 6, Component of Oligomeric Golgi Complex 6, KIAA1134, DKFZp313D191) |
||
| MBS6001835-5x01mg | 5x0.1mg | EUR 2680 |
COG4 (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4, DKFZp586E1519, DKFZP586E1519) |
||
| MBS648838-01mg | 0.1mg | EUR 630 |
COG4 (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4, DKFZp586E1519, DKFZP586E1519) |
||
| MBS648838-5x01mg | 5x0.1mg | EUR 2680 |
COG1 (Conserved Oligomeric Golgi Complex Subunit 1, COG Complex Subunit 1, Component of Oligomeric Golgi Complex 1, COG1, KIAA1381, LDLB) (AP) |
||
| MBS6455216-02mL | 0.2mL | EUR 980 |
COG1 (Conserved Oligomeric Golgi Complex Subunit 1, COG Complex Subunit 1, Component of Oligomeric Golgi Complex 1, COG1, KIAA1381, LDLB) (AP) |
||
| MBS6455216-5x02mL | 5x0.2mL | EUR 4250 |
COG1 (Conserved Oligomeric Golgi Complex Subunit 1, COG Complex Subunit 1, Component of Oligomeric Golgi Complex 1, COG1, KIAA1381, LDLB) (APC) |
||
| MBS6455217-02mL | 0.2mL | EUR 980 |
COG1 (Conserved Oligomeric Golgi Complex Subunit 1, COG Complex Subunit 1, Component of Oligomeric Golgi Complex 1, COG1, KIAA1381, LDLB) (APC) |
||
| MBS6455217-5x02mL | 5x0.2mL | EUR 4250 |
COG1 (Conserved Oligomeric Golgi Complex Subunit 1, COG Complex Subunit 1, Component of Oligomeric Golgi Complex 1, COG1, KIAA1381, LDLB) (HRP) |
||
| MBS6455220-02mL | 0.2mL | EUR 980 |
COG1 (Conserved Oligomeric Golgi Complex Subunit 1, COG Complex Subunit 1, Component of Oligomeric Golgi Complex 1, COG1, KIAA1381, LDLB) (HRP) |
||
| MBS6455220-5x02mL | 5x0.2mL | EUR 4250 |
COG1 (Conserved Oligomeric Golgi Complex Subunit 1, COG Complex Subunit 1, Component of Oligomeric Golgi Complex 1, COG1, KIAA1381, LDLB) (PE) |
||
| MBS6455226-02mL | 0.2mL | EUR 980 |
COG1 (Conserved Oligomeric Golgi Complex Subunit 1, COG Complex Subunit 1, Component of Oligomeric Golgi Complex 1, COG1, KIAA1381, LDLB) (PE) |
||
| MBS6455226-5x02mL | 5x0.2mL | EUR 4250 |
COG1 (Conserved Oligomeric Golgi Complex Subunit 1, COG Complex Subunit 1, Component of Oligomeric Golgi Complex 1, COG1, KIAA1381, LDLB) (Biotin) |
||
| MBS6455218-02mL | 0.2mL | EUR 980 |
COG1 (Conserved Oligomeric Golgi Complex Subunit 1, COG Complex Subunit 1, Component of Oligomeric Golgi Complex 1, COG1, KIAA1381, LDLB) (Biotin) |
||
| MBS6455218-5x02mL | 5x0.2mL | EUR 4250 |
COG1 (Conserved Oligomeric Golgi Complex Subunit 1, COG Complex Subunit 1, Component of Oligomeric Golgi Complex 1, COG1, KIAA1381, LDLB) (FITC) |
||
| MBS6455219-02mL | 0.2mL | EUR 980 |
COG1 (Conserved Oligomeric Golgi Complex Subunit 1, COG Complex Subunit 1, Component of Oligomeric Golgi Complex 1, COG1, KIAA1381, LDLB) (FITC) |
||
| MBS6455219-5x02mL | 5x0.2mL | EUR 4250 |
COG4, CT (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4) (MaxLight 405) |
||
| MBS6469594-01mL | 0.1mL | EUR 980 |
COG4, CT (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4) (MaxLight 405) |
||
| MBS6469594-5x01mL | 5x0.1mL | EUR 4250 |
COG4, CT (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4) (MaxLight 490) |
||
| MBS6469595-01mL | 0.1mL | EUR 980 |
COG4, CT (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4) (MaxLight 490) |
||
| MBS6469595-5x01mL | 5x0.1mL | EUR 4250 |
COG4, CT (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4) (MaxLight 550) |
||
| MBS6469596-01mL | 0.1mL | EUR 980 |
COG4, CT (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4) (MaxLight 550) |
||
| MBS6469596-5x01mL | 5x0.1mL | EUR 4250 |
COG4, CT (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4) (MaxLight 650) |
||
| MBS6469597-01mL | 0.1mL | EUR 980 |
COG4, CT (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4) (MaxLight 650) |
||
| MBS6469597-5x01mL | 5x0.1mL | EUR 4250 |
COG4, CT (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4) (MaxLight 750) |
||
| MBS6469598-01mL | 0.1mL | EUR 980 |
COG4, CT (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4) (MaxLight 750) |
||
| MBS6469598-5x01mL | 5x0.1mL | EUR 4250 |
ML-133 (hydrochloride) |
||
| 462952 | 5.0mg | EUR 260 |
nhr-133 Antibody |
||
| CSB-PA519419XA01CXY-02mg | 0.2mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans nhr-133 protein |
||
nhr-133 Antibody |
||
| CSB-PA519419XA01CXY-10mg | 10mg | Ask for price |
|
Description: Recombinant Caenorhabditis elegans nhr-133 protein |
||
CREB (Ab-133) |
||
| ANTY021052 | 100ug | EUR 259 |
Antibacterial agent 133 |
||
| HY-152252 | Get quote | Ask for price |
|
Description: Antibacterial agent 133 (4l) is an antimicrobial agent that has shown anti-Candida activity, particularly through LMD enzyme inhibition. Antibacterial agent 133 shows MIC90 values of 1.95 μg/mL against Candida albicans ATCC 24433, Candida smoothis ATCC 90030 and Candida subtilis ATCC 22019[1]. |
||
JW 133-d5 |
||
| J211337 | 100mg | EUR 21000 |
Anticancer agent 133 |
||
| HY-149344 | Get quote | Ask for price |
|
Description: Anticancer agent 133 (compound Rh2) is an anti-cancer agent with cytotoxic and antimetastatic activities. Anticancer agent 133 induces cell cycle arrest, apoptosis, and autophagy. Anticancer agent 133 also inhibits cell metastasis via suppression of EGFR expression mediated by FAK-regulated integrin β1[1]. |
||
Antitumor agent-133 |
||
| HY-157548 | Get quote | Ask for price |
|
Description: Antitumor agent-133 (compound 4d) is a bis-isatin derivative, with activities against Huh1 (IC50=17.13 μM) and Huh7 (IC50=8.27 μM). Antitumor agent-133 induces cell autophagy and inhibits tumor growth through regulation of LC3BII, ATG5 and p62 proteins[1]. |
||
ML 133 Hydrochloride |
||
| M425075 | 10mg | EUR 75 |
Antibiotic NFAT 133 |
||
| T125647-10mg | 10mg | Ask for price |
|
Description: Antibiotic NFAT 133 |
||
Antibiotic NFAT 133 |
||
| T125647-1g | 1g | Ask for price |
|
Description: Antibiotic NFAT 133 |
||
Antibiotic NFAT 133 |
||
| T125647-1mg | 1mg | Ask for price |
|
Description: Antibiotic NFAT 133 |
||
Antibiotic NFAT 133 |
||
| T125647-50mg | 50mg | Ask for price |
|
Description: Antibiotic NFAT 133 |
||
Antibiotic NFAT 133 |
||
| T125647-5mg | 5mg | Ask for price |
|
Description: Antibiotic NFAT 133 |
||
COG6 (Conserved Oligomeric Golgi Complex Subunit 6, COG Complex Subunit 6, Component of Oligomeric Golgi Complex 6, KIAA1134, DKFZp313D191) (PE) |
||
| MBS6157192-01mL | 0.1(mL | EUR 875 |
COG6 (Conserved Oligomeric Golgi Complex Subunit 6, COG Complex Subunit 6, Component of Oligomeric Golgi Complex 6, KIAA1134, DKFZp313D191) (PE) |
||
| MBS6157192-5x01mL | 5x0.1mL | EUR 3800 |
COG6 (Conserved Oligomeric Golgi Complex Subunit 6, COG Complex Subunit 6, Component of Oligomeric Golgi Complex 6, KIAA1134, DKFZp313D191) (AP) |
||
| MBS6130677-01mL | 0.1(mL | EUR 875 |
COG6 (Conserved Oligomeric Golgi Complex Subunit 6, COG Complex Subunit 6, Component of Oligomeric Golgi Complex 6, KIAA1134, DKFZp313D191) (AP) |
||
| MBS6130677-5x01mL | 5x0.1mL | EUR 3800 |
COG6 (Conserved Oligomeric Golgi Complex Subunit 6, COG Complex Subunit 6, Component of Oligomeric Golgi Complex 6, KIAA1134, DKFZp313D191) APC |
||
| MBS6135980-01mL | 0.1(mL | EUR 875 |
COG6 (Conserved Oligomeric Golgi Complex Subunit 6, COG Complex Subunit 6, Component of Oligomeric Golgi Complex 6, KIAA1134, DKFZp313D191) APC |
||
| MBS6135980-5x01mL | 5x0.1mL | EUR 3800 |
COG6 (Conserved Oligomeric Golgi Complex Subunit 6, COG Complex Subunit 6, Component of Oligomeric Golgi Complex 6, KIAA1134, DKFZp313D191) (FITC) |
||
| MBS6146586-01mL | 0.1(mL | EUR 875 |
COG6 (Conserved Oligomeric Golgi Complex Subunit 6, COG Complex Subunit 6, Component of Oligomeric Golgi Complex 6, KIAA1134, DKFZp313D191) (FITC) |
||
| MBS6146586-5x01mL | 5x0.1mL | EUR 3800 |
COG6 (Conserved Oligomeric Golgi Complex Subunit 6, COG Complex Subunit 6, Component of Oligomeric Golgi Complex 6, KIAA1134, DKFZp313D191) (HRP) |
||
| MBS6151889-01mL | 0.1(mL | EUR 875 |
COG6 (Conserved Oligomeric Golgi Complex Subunit 6, COG Complex Subunit 6, Component of Oligomeric Golgi Complex 6, KIAA1134, DKFZp313D191) (HRP) |
||
| MBS6151889-5x01mL | 5x0.1mL | EUR 3800 |
COG4 (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4, DKFZp586E1519, DKFZP586E1519) (PE) |
||
| MBS6157191-01mL | 0.1(mL | EUR 875 |
COG4 (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4, DKFZp586E1519, DKFZP586E1519) (PE) |
||
| MBS6157191-5x01mL | 5x0.1mL | EUR 3800 |
COG4 (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4, DKFZp586E1519, DKFZP586E1519) (AP) |
||
| MBS6130676-01mL | 0.1(mL | EUR 875 |
COG4 (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4, DKFZp586E1519, DKFZP586E1519) (AP) |
||
| MBS6130676-5x01mL | 5x0.1mL | EUR 3800 |
COG4 (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4, DKFZp586E1519, DKFZP586E1519) APC |
||
| MBS6135979-01mL | 0.1(mL | EUR 875 |
COG4 (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4, DKFZp586E1519, DKFZP586E1519) APC |
||
| MBS6135979-5x01mL | 5x0.1mL | EUR 3800 |
COG6 (Conserved Oligomeric Golgi Complex Subunit 6, COG Complex Subunit 6, Component of Oligomeric Golgi Complex 6, KIAA1134, DKFZp313D191) (Biotin) |
||
| MBS6141283-01mL | 0.1(mL | EUR 875 |
COG6 (Conserved Oligomeric Golgi Complex Subunit 6, COG Complex Subunit 6, Component of Oligomeric Golgi Complex 6, KIAA1134, DKFZp313D191) (Biotin) |
||
| MBS6141283-5x01mL | 5x0.1mL | EUR 3800 |
COG4 (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4, DKFZp586E1519, DKFZP586E1519) (HRP) |
||
| MBS6151888-01mL | 0.1(mL | EUR 875 |
COG4 (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4, DKFZp586E1519, DKFZP586E1519) (HRP) |
||
| MBS6151888-5x01mL | 5x0.1mL | EUR 3800 |
COG4 (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4, DKFZp586E1519, DKFZP586E1519) (FITC) |
||
| MBS6146585-01mL | 0.1(mL | EUR 875 |
COG4 (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4, DKFZp586E1519, DKFZP586E1519) (FITC) |
||
| MBS6146585-5x01mL | 5x0.1mL | EUR 3800 |
COG4 (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4, DKFZp586E1519, DKFZP586E1519) (Biotin) |
||
| MBS6141282-01mL | 0.1(mL | EUR 875 |
COG4 (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4, DKFZp586E1519, DKFZP586E1519) (Biotin) |
||
| MBS6141282-5x01mL | 5x0.1mL | EUR 3800 |
COG1 (Conserved Oligomeric Golgi Complex Subunit 1, COG Complex Subunit 1, Component of Oligomeric Golgi Complex 1, COG1, KIAA1381, LDLB) (MaxLight 405) |
||
| MBS6455221-01mL | 0.1mL | EUR 980 |
COG1 (Conserved Oligomeric Golgi Complex Subunit 1, COG Complex Subunit 1, Component of Oligomeric Golgi Complex 1, COG1, KIAA1381, LDLB) (MaxLight 405) |
||
| MBS6455221-5x01mL | 5x0.1mL | EUR 4250 |
COG1 (Conserved Oligomeric Golgi Complex Subunit 1, COG Complex Subunit 1, Component of Oligomeric Golgi Complex 1, COG1, KIAA1381, LDLB) (MaxLight 490) |
||
| MBS6455222-01mL | 0.1mL | EUR 980 |
COG1 (Conserved Oligomeric Golgi Complex Subunit 1, COG Complex Subunit 1, Component of Oligomeric Golgi Complex 1, COG1, KIAA1381, LDLB) (MaxLight 490) |
||
| MBS6455222-5x01mL | 5x0.1mL | EUR 4250 |
COG1 (Conserved Oligomeric Golgi Complex Subunit 1, COG Complex Subunit 1, Component of Oligomeric Golgi Complex 1, COG1, KIAA1381, LDLB) (MaxLight 550) |
||
| MBS6455223-01mL | 0.1mL | EUR 980 |
COG1 (Conserved Oligomeric Golgi Complex Subunit 1, COG Complex Subunit 1, Component of Oligomeric Golgi Complex 1, COG1, KIAA1381, LDLB) (MaxLight 550) |
||
| MBS6455223-5x01mL | 5x0.1mL | EUR 4250 |
COG1 (Conserved Oligomeric Golgi Complex Subunit 1, COG Complex Subunit 1, Component of Oligomeric Golgi Complex 1, COG1, KIAA1381, LDLB) (MaxLight 650) |
||
| MBS6455224-01mL | 0.1mL | EUR 980 |
COG1 (Conserved Oligomeric Golgi Complex Subunit 1, COG Complex Subunit 1, Component of Oligomeric Golgi Complex 1, COG1, KIAA1381, LDLB) (MaxLight 650) |
||
| MBS6455224-5x01mL | 5x0.1mL | EUR 4250 |
COG1 (Conserved Oligomeric Golgi Complex Subunit 1, COG Complex Subunit 1, Component of Oligomeric Golgi Complex 1, COG1, KIAA1381, LDLB) (MaxLight 750) |
||
| MBS6455225-01mL | 0.1mL | EUR 980 |
COG1 (Conserved Oligomeric Golgi Complex Subunit 1, COG Complex Subunit 1, Component of Oligomeric Golgi Complex 1, COG1, KIAA1381, LDLB) (MaxLight 750) |
||
| MBS6455225-5x01mL | 5x0.1mL | EUR 4250 |
Musclin (83-133) / Osteocrin (Ostn) (83-133) (Human) - Antibody |
||
| H-028-68 | 100 μl | EUR 469.8 |
COG7 (Conserved Oligomeric Golgi Complex Component 7, COG Complex Subunit 7, Component of Oligomeric Golgi Complex 7, CDG2E, UNQ3082/PRO10013) (PE) |
||
| MBS6157193-01mL | 0.1(mL | EUR 875 |
COG7 (Conserved Oligomeric Golgi Complex Component 7, COG Complex Subunit 7, Component of Oligomeric Golgi Complex 7, CDG2E, UNQ3082/PRO10013) (PE) |
||
| MBS6157193-5x01mL | 5x0.1mL | EUR 3800 |
COG7 (Conserved Oligomeric Golgi Complex Component 7, COG Complex Subunit 7, Component of Oligomeric Golgi Complex 7, CDG2E, UNQ3082/PRO10013) (AP) |
||
| MBS6130678-01mL | 0.1(mL | EUR 875 |
COG7 (Conserved Oligomeric Golgi Complex Component 7, COG Complex Subunit 7, Component of Oligomeric Golgi Complex 7, CDG2E, UNQ3082/PRO10013) (AP) |
||
| MBS6130678-5x01mL | 5x0.1mL | EUR 3800 |
COG7 (Conserved Oligomeric Golgi Complex Component 7, COG Complex Subunit 7, Component of Oligomeric Golgi Complex 7, CDG2E, UNQ3082/PRO10013) APC |
||
| MBS6135981-01mL | 0.1(mL | EUR 875 |
COG7 (Conserved Oligomeric Golgi Complex Component 7, COG Complex Subunit 7, Component of Oligomeric Golgi Complex 7, CDG2E, UNQ3082/PRO10013) APC |
||
| MBS6135981-5x01mL | 5x0.1mL | EUR 3800 |
COG7 (Conserved Oligomeric Golgi Complex Component 7, COG Complex Subunit 7, Component of Oligomeric Golgi Complex 7, CDG2E, UNQ3082/PRO10013) (FITC) |
||
| MBS6146587-01mL | 0.1(mL | EUR 875 |
COG7 (Conserved Oligomeric Golgi Complex Component 7, COG Complex Subunit 7, Component of Oligomeric Golgi Complex 7, CDG2E, UNQ3082/PRO10013) (FITC) |
||
| MBS6146587-5x01mL | 5x0.1mL | EUR 3800 |
COG7 (Conserved Oligomeric Golgi Complex Component 7, COG Complex Subunit 7, Component of Oligomeric Golgi Complex 7, CDG2E, UNQ3082/PRO10013) (HRP) |
||
| MBS6151890-01mL | 0.1(mL | EUR 875 |
COG7 (Conserved Oligomeric Golgi Complex Component 7, COG Complex Subunit 7, Component of Oligomeric Golgi Complex 7, CDG2E, UNQ3082/PRO10013) (HRP) |
||
| MBS6151890-5x01mL | 5x0.1mL | EUR 3800 |
COG7 (Conserved Oligomeric Golgi Complex Component 7, COG Complex Subunit 7, Component of Oligomeric Golgi Complex 7, CDG2E, UNQ3082/PRO10013) (Biotin) |
||
| MBS6141284-01mL | 0.1(mL | EUR 875 |
COG7 (Conserved Oligomeric Golgi Complex Component 7, COG Complex Subunit 7, Component of Oligomeric Golgi Complex 7, CDG2E, UNQ3082/PRO10013) (Biotin) |
||
| MBS6141284-5x01mL | 5x0.1mL | EUR 3800 |
COG6 (Conserved Oligomeric Golgi Complex Subunit 6, COG Complex Subunit 6, Component of Oligomeric Golgi Complex 6, KIAA1134, DKFZp313D191) (MaxLight 650) |
||
| MBS6221565-01mL | 0.1(mL | EUR 875 |
COG6 (Conserved Oligomeric Golgi Complex Subunit 6, COG Complex Subunit 6, Component of Oligomeric Golgi Complex 6, KIAA1134, DKFZp313D191) (MaxLight 650) |
||
| MBS6221565-5x01mL | 5x0.1mL | EUR 3800 |
COG6 (Conserved Oligomeric Golgi Complex Subunit 6, COG Complex Subunit 6, Component of Oligomeric Golgi Complex 6, KIAA1134, DKFZp313D191) (MaxLight 490) |
||
| MBS6200215-01mL | 0.1(mL | EUR 875 |
COG6 (Conserved Oligomeric Golgi Complex Subunit 6, COG Complex Subunit 6, Component of Oligomeric Golgi Complex 6, KIAA1134, DKFZp313D191) (MaxLight 490) |
||
| MBS6200215-5x01mL | 5x0.1mL | EUR 3800 |
COG6 (Conserved Oligomeric Golgi Complex Subunit 6, COG Complex Subunit 6, Component of Oligomeric Golgi Complex 6, KIAA1134, DKFZp313D191) (MaxLight 405) |
||
| MBS6189540-01mL | 0.1(mL | EUR 875 |
COG6 (Conserved Oligomeric Golgi Complex Subunit 6, COG Complex Subunit 6, Component of Oligomeric Golgi Complex 6, KIAA1134, DKFZp313D191) (MaxLight 405) |
||
| MBS6189540-5x01mL | 5x0.1mL | EUR 3800 |
COG6 (Conserved Oligomeric Golgi Complex Subunit 6, COG Complex Subunit 6, Component of Oligomeric Golgi Complex 6, KIAA1134, DKFZp313D191) (MaxLight 550) |
||
| MBS6210890-01mL | 0.1(mL | EUR 875 |
COG6 (Conserved Oligomeric Golgi Complex Subunit 6, COG Complex Subunit 6, Component of Oligomeric Golgi Complex 6, KIAA1134, DKFZp313D191) (MaxLight 550) |
||
| MBS6210890-5x01mL | 5x0.1mL | EUR 3800 |
COG6 (Conserved Oligomeric Golgi Complex Subunit 6, COG Complex Subunit 6, Component of Oligomeric Golgi Complex 6, KIAA1134, DKFZp313D191) (MaxLight 750) |
||
| MBS6232240-01mL | 0.1(mL | EUR 875 |
COG6 (Conserved Oligomeric Golgi Complex Subunit 6, COG Complex Subunit 6, Component of Oligomeric Golgi Complex 6, KIAA1134, DKFZp313D191) (MaxLight 750) |
||
| MBS6232240-5x01mL | 5x0.1mL | EUR 3800 |
COG4 (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4, DKFZp586E1519, DKFZP586E1519) (MaxLight 650) |
||
| MBS6221564-01mL | 0.1(mL | EUR 875 |
COG4 (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4, DKFZp586E1519, DKFZP586E1519) (MaxLight 650) |
||
| MBS6221564-5x01mL | 5x0.1mL | EUR 3800 |
COG4 (Component Of Oligomeric Golgi Complex 4, Conserved Oligomeric Golgi Complex Subunit 4, COG Complex Subunit 4, DKFZp586E1519, DKFZP586E1519) (MaxLight 490) |
||
| MBS6200214-01mL | 0.1(mL | EUR 875 |